An overview of the genetics of ABCA4 retinopathies, an evolving story
Stargardt disease (STGD1) and ABCA4 retinopathies (ABCA4R) are caused by pathogenic variants in the ABCA4 gene inherited in an autosomal recessive manner. The gene encodes an importer flippase protein that prevents the build-up of vitamin A derivatives that are toxic to the RPE. Diagnosing ABCA4R is...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
MDPI
2021
|
| _version_ | 1797084782998323200 |
|---|---|
| author | Al-Khuzaei, S Broadgate, S Foster, CR Shah, M Yu, J Downes, SM Halford, S |
| author_facet | Al-Khuzaei, S Broadgate, S Foster, CR Shah, M Yu, J Downes, SM Halford, S |
| author_sort | Al-Khuzaei, S |
| collection | OXFORD |
| description | Stargardt disease (STGD1) and ABCA4 retinopathies (ABCA4R) are caused by pathogenic variants in the ABCA4 gene inherited in an autosomal recessive manner. The gene encodes an importer flippase protein that prevents the build-up of vitamin A derivatives that are toxic to the RPE. Diagnosing ABCA4R is complex due to its phenotypic variability and the presence of other inherited retinal dystrophy phenocopies. ABCA4 is a large gene, comprising 50 exons; to date > 2000 variants have been described. These include missense, nonsense, splicing, structural, and deep intronic variants. Missense variants account for the majority of variants in ABCA4. However, in a significant proportion of patients with an ABCA4R phenotype, a second variant in ABCA4 is not identified. This could be due to the presence of yet unknown variants, or hypomorphic alleles being incorrectly classified as benign, or the possibility that the disease is caused by a variant in another gene. This underlines the importance of accurate genetic testing. The pathogenicity of novel variants can be predicted using in silico programs, but these rely on databases that are not ethnically diverse, thus highlighting the need for studies in differing populations. Functional studies in vitro are useful towards assessing protein function but do not directly measure the flippase activity. Obtaining an accurate molecular diagnosis is becoming increasingly more important as targeted therapeutic options become available; these include pharmacological, gene-based, and cell replacement-based therapies. The aim of this review is to provide an update on the current status of genotyping in ABCA4 and the status of the therapeutic approaches being investigated. |
| first_indexed | 2024-03-07T01:59:52Z |
| format | Journal article |
| id | oxford-uuid:9cf9e69b-10d0-4b52-b2d0-3df546d62bb9 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T01:59:52Z |
| publishDate | 2021 |
| publisher | MDPI |
| record_format | dspace |
| spelling | oxford-uuid:9cf9e69b-10d0-4b52-b2d0-3df546d62bb92022-03-27T00:39:52ZAn overview of the genetics of ABCA4 retinopathies, an evolving storyJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:9cf9e69b-10d0-4b52-b2d0-3df546d62bb9EnglishSymplectic ElementsMDPI2021Al-Khuzaei, SBroadgate, SFoster, CRShah, MYu, JDownes, SMHalford, SStargardt disease (STGD1) and ABCA4 retinopathies (ABCA4R) are caused by pathogenic variants in the ABCA4 gene inherited in an autosomal recessive manner. The gene encodes an importer flippase protein that prevents the build-up of vitamin A derivatives that are toxic to the RPE. Diagnosing ABCA4R is complex due to its phenotypic variability and the presence of other inherited retinal dystrophy phenocopies. ABCA4 is a large gene, comprising 50 exons; to date > 2000 variants have been described. These include missense, nonsense, splicing, structural, and deep intronic variants. Missense variants account for the majority of variants in ABCA4. However, in a significant proportion of patients with an ABCA4R phenotype, a second variant in ABCA4 is not identified. This could be due to the presence of yet unknown variants, or hypomorphic alleles being incorrectly classified as benign, or the possibility that the disease is caused by a variant in another gene. This underlines the importance of accurate genetic testing. The pathogenicity of novel variants can be predicted using in silico programs, but these rely on databases that are not ethnically diverse, thus highlighting the need for studies in differing populations. Functional studies in vitro are useful towards assessing protein function but do not directly measure the flippase activity. Obtaining an accurate molecular diagnosis is becoming increasingly more important as targeted therapeutic options become available; these include pharmacological, gene-based, and cell replacement-based therapies. The aim of this review is to provide an update on the current status of genotyping in ABCA4 and the status of the therapeutic approaches being investigated. |
| spellingShingle | Al-Khuzaei, S Broadgate, S Foster, CR Shah, M Yu, J Downes, SM Halford, S An overview of the genetics of ABCA4 retinopathies, an evolving story |
| title | An overview of the genetics of ABCA4 retinopathies, an evolving story |
| title_full | An overview of the genetics of ABCA4 retinopathies, an evolving story |
| title_fullStr | An overview of the genetics of ABCA4 retinopathies, an evolving story |
| title_full_unstemmed | An overview of the genetics of ABCA4 retinopathies, an evolving story |
| title_short | An overview of the genetics of ABCA4 retinopathies, an evolving story |
| title_sort | overview of the genetics of abca4 retinopathies an evolving story |
| work_keys_str_mv | AT alkhuzaeis anoverviewofthegeneticsofabca4retinopathiesanevolvingstory AT broadgates anoverviewofthegeneticsofabca4retinopathiesanevolvingstory AT fostercr anoverviewofthegeneticsofabca4retinopathiesanevolvingstory AT shahm anoverviewofthegeneticsofabca4retinopathiesanevolvingstory AT yuj anoverviewofthegeneticsofabca4retinopathiesanevolvingstory AT downessm anoverviewofthegeneticsofabca4retinopathiesanevolvingstory AT halfords anoverviewofthegeneticsofabca4retinopathiesanevolvingstory AT alkhuzaeis overviewofthegeneticsofabca4retinopathiesanevolvingstory AT broadgates overviewofthegeneticsofabca4retinopathiesanevolvingstory AT fostercr overviewofthegeneticsofabca4retinopathiesanevolvingstory AT shahm overviewofthegeneticsofabca4retinopathiesanevolvingstory AT yuj overviewofthegeneticsofabca4retinopathiesanevolvingstory AT downessm overviewofthegeneticsofabca4retinopathiesanevolvingstory AT halfords overviewofthegeneticsofabca4retinopathiesanevolvingstory |